free web stats

A Prophylactic CMV Vaccine Designed to Prevent Congenital Infection Using Enveloped Virus-Like Particles

By September 15, 2014Conferences, Cytomegalovirus ("CMV")

The presentation, A Prophylactic Human Cytomegalovirus (HCMV) Vaccine Designed to Prevent Congenital Infection Using Enveloped Virus-Like-Particles (eVLPs), was delivered by Dr. David E. Anderson, VBI’s Senior Vice President of Research, at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Conference held in Washington, D.C. on September 7th, 2014. Download the Presentation >>